Misty Robotics Launches Temp Screening Assistant: First of A Kind Approach to Onsite Temperature Screening

Jue 23, 2020

Misty Robotics, the creators of the Misty II platform robot, today announced the launch of the Temp Screening Assistant.

Misty Robotics notes this is the only temperature screening solution to employ a robot with character, Misty II. It addresses a company’s health screening needs with the added value of delivering a great user experience. Employees, customers, and visitors will appreciate the novelty of interacting with a clever and personable robot, who engages dynamically, both visually and verbally. A first of its kind, the Temp Screening Assistant is an opportunity to reinforce a strong people culture and customer-centric brand.

The Temp Screening Assistant for Misty II is an automated, contactless, and touchless solution for screening and detecting individuals with an elevated temperature and other health risk factors associated with COVID-19 infection. Companies benefit from reduced risk to their frontline staff and the elimination of surface hygiene concerns associated with touch-based systems. Screening is consistent, reliable and most of all friendly.

“This is different from any other solution for temperature screening on the market. It isn’t a tablet. It isn’t a kiosk. It isn’t a human with a no touch thermometer. Misty II in the role of temperature screener is a new kind of assistant, who can make the whole temperature screening process pleasant and memorable. Thanks to where robot technology and the study of Human Robot Interaction (HRI) have evolved, it’s now very feasible to have an affordable and engaging robot experience, which is far better than the very dry kiosk-based experience,” said Tim Enwall, CEO Misty Robotics.

Capabilities of the Temp Screening Assistant Core edition include: temperature screening using a high accuracy, blackbody referenced thermal imaging camera (accuracy within +/- 0.5 C), an interactive health question survey, immediate pass/fail result determination and recording, configurable SMS and/or email notifications, and web-based administration and reporting. Companies can upgrade to the Specialized edition which has an additional custom yes/no question capability, choice of available languages, custom greetings and the ability to elect to not store screening data.

With the Temp Screening Assistant companies have a cost-effective solution that is easy to use, easy to maintain and easy to manage. (A consistently friendly attitude comes standard.) When compared to human-based solutions it is a fraction of the hourly cost of a human and no PPE is required. This is an advanced approach making tablet-based approaches feel very yesteryear.

The Temp Screening Assistant is a future-proof investment. Misty II has ongoing utility well after the need for COVID-19 screening. She can be put on the assignment of a general office assistant or any of the assignments found in the Misty Robotics Solution Hub. As a platform robot, a company’s in-house software developers can also build new skills (robot applications) for her.

“Robot (as a temperature screener) really hit a lightbulb for me. It was amazing. Smart solutions for a modern problem,” stated David Torres, Safety Program Coordinator, North America, Twilio.

“Misty’s arrival at our site comes at a time when everyone could benefit from additional interactions that are positive and consistent,” stated Per Schenck, Health and Safety Coordinator Mental Health Partners.

Both the Core and Specialized editions will be available for pilot deployments starting mid-July. Pricing for the Temp Screener Assistant starts at $2,999 + a modest monthly fee. A leasing model is also available.

The Temp Screening Assistant application is being announced at Collision from Home 2020.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution